<table><thead><tr><td>Particulars</td><td>As of and for the Financial Year ended March 31, 2023</td><td>As of and for the Financial Year ended March 31, 2024</td><td>As of and for the Financial Year ended March 31, 2025</td><td>From April 1, 2025, till the date of this Draft Red Herring Prospectus</td></tr></thead><tbody><tr><td>had used fair value of options and impact of this difference on profits and EPS of our Company for the last three fiscals</td><td colspan="3">ESOP 2023 Plan 2 for the options granted during the Financial Year ended March 31, 2023</td><td></td></tr><tr><td>Description of the pricing formula and the method and significant assumptions used during the year to estimate the fair values of options, including weighted-average information, namely, risk-free interest rate, expected life, expected volatility, expected dividends and the price of the underlying share in market at the time of grant of the option</td><td colspan="3"></td><td>Refer note (a)</td></tr><tr><td>Impact on profits and EPS of the last three years if our Company had followed the accounting policies specified in Regulation 15 of the SEBI ESOP Regulations in respect of options granted in the last three years</td><td colspan="3"></td><td>N.A.</td></tr><tr><td>Intention of the key managerial personnel, senior management, and whole-time directors who are holders of equity shares allotted on exercise of options granted, to sell their Equity Shares within three months after the date of listing of Equity Shares pursuant to the Offer, if any whether the equity shares arise out of options exercised before or after the Offer</td><td colspan="3"></td><td>N.A.</td></tr><tr><td>Intention to sell Equity Shares arising out of, or allotted under an employee stock option scheme within three months after the date of listing of Equity Shares, by Directors, key managerial personnel, senior management and employees having Equity Shares arising out of an employee stock option scheme, amounting to more than 1% of the issued capital (excluding outstanding warrants and conversions) which inter alia shall include name, designation and quantum of the equity shares issued under an employee stock option scheme or employee stock purchase scheme and the quantum they intend to sell within three months</td><td colspan="3"></td><td>N.A.</td></tr></tbody></table>

Note (a)

Description of the pricing formula and the method and significant assumptions used during the year to estimate the fair values of options, including weighted-average information, namely, risk-free interest rate, expected life, expected volatility, expected dividends and the price of the underlying share in market at the time of grant of the option: